Singapore markets open in 2 hours 49 minutes
Straits Times Index
3,300.04 -3.15 (-0.10%) S&P 500
5,187.70 +6.96 (+0.13%) Dow
38,884.26 +31.99 (+0.08%) Nasdaq
16,332.56 -16.69 (-0.10%) Bitcoin USD
62,952.40 -575.13 (-0.91%) CMC Crypto 200
1,308.29 -56.83 (-4.16%)
Vicapsys Life Sciences, Inc. (VICP)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 09:37AM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 31.75M |
| Enterprise value | 32.00M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.00 |
| Price/book (mrq) | 0.02 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -44.37 |
Trading information
Stock price history
| Beta (5Y monthly) | -5.99 |
| 52-week change 3 | -1.01% |
| S&P500 52-week change 3 | 25.77% |
| 52-week high 3 | 3.0000 |
| 52-week low 3 | 0.4440 |
| 50-day moving average 3 | 1.4898 |
| 200-day moving average 3 | 1.8350 |
Share statistics
| Avg vol (3-month) 3 | 82 |
| Avg vol (10-day) 3 | 124 |
| Shares outstanding 5 | 32.07M |
| Implied shares outstanding 6 | 32.07M |
| Float 8 | 13.85M |
| % held by insiders 1 | 56.82% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 02 Nov 2017 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:100 |
| Last split date 3 | 02 Nov 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -141.85% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -640.86k |
| Net income avi to common (ttm) | -1.08M |
| Diluted EPS (ttm) | -0.0300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 53.53k |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 307.25k |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.14 |
| Book value per share (mrq) | -0.04 |
Cash flow statement
| Operating cash flow (ttm) | -332.58k |
| Levered free cash flow (ttm) | -86.89k |
© 2024 Yahoo. All rights reserved.